Opcom announced that the actual capital raised by issuing shares to specific targets in June 2022 was 1,494 billion yuan, which was stored in a special account. In the first half of 2026, 72.3758 million yuan was directly invested in fund-raising projects. As of June 30, 2026, a total of 713 million yuan of raised capital had been used. The balance of raised funds had not yet been used, of which 655 million yuan was used to purchase cash management products, with a special account balance of 112 million yuan. The “Contact Lens and Supporting Product Industrialization Project” and “Suqian Shangyue Qicheng 75% Equity Acquisition Project” have been completed. The savings have all been replenished with working capital, and the corresponding special account has been cancelled. The community-based optometry service terminal construction project was postponed until May 2029.

Opcom announced that the actual capital raised by issuing shares to specific targets in June 2022 was 1,494 billion yuan, which was stored in a special account. In the first half of 2026, 72.3758 million yuan was directly invested in fund-raising projects. As of June 30, 2026, a total of 713 million yuan of raised capital had been used. The balance of raised funds had not yet been used, of which 655 million yuan was used to purchase cash management products, with a special account balance of 112 million yuan. The “Contact Lens and Supporting Product Industrialization Project” and “Suqian Shangyue Qicheng 75% Equity Acquisition Project” have been completed. The savings have all been replenished with working capital, and the corresponding special account has been cancelled. The community-based optometry service terminal construction project was postponed until May 2029.